Myriam Delaunay
31 works · 1,163 citations · h-index 11
Top works
- Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
- PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab
- Management of pulmonary toxicity associated with immune checkpoint inhibitors
- Monitoring of KRAS-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinoma
- Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer
- Immune Checkpoint Inhibitors Rechallenge Efficacy in Non–Small-Cell Lung Cancer Patients
- ICU admission for solid cancer patients treated with immune checkpoint inhibitors
- Targeting the immune system to treat lung cancer: rationale and clinical experience
- Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer.
- Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy
- Toxicité des inhibiteurs de points de contrôle immunitaires
- MA07.05 Immune Checkpoint Inhibitor (ICPi) Re-Challenge: Outcomes Analysis in a French National Cohort of Non-Small-Cell Lung Cancer (NSCLC) Patients
- Baseline circulating myeloid-derived suppressor cells and response to PD-1 inhibitor in non-small cell lung cancer patients.
- Immunothérapie et cancer du poumon : où en sommes-nous ?
- Early prediction of outcomes to PD1 inhibitors in non-small cell lung cancer (NSCLC) using next generation sequencing (NGS) of plasma circulating tumor DNA (ctDNA).
- Monitoring PD-L1 expression on circulating tumor cells (CTCs) in patients with NSCLC treated with PD1 inhibitors.
- P3.02c-032 Interstitial Pneumonitis Associated with Immune Checkpoint Inhibitors Treatment in Cancer Patients
- Epidemiological disparities in pulmonary sarcoidosis between public and private healthcare sectors in haute-Garonne department (France)
- 1911P Implementation of remote patient monitoring in thoracic oncology: A real-world experience from 489 pts across 41 centers in France
- Caractéristiques des pneumopathies interstitielles diffuses survenant chez des patients traités par les inhibiteurs des points de contrôle immunitaire